FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2894907175> ?p ?o ?g. }

• W2894907175 endingPage "55" @default.
• W2894907175 startingPage "46" @default.
• W2894907175 abstract "Up to 25,000 people die each year from resistant infections in Europe alone, with increasing incidence. It is estimated that a continued rise in bacterial resistance by 2050 would lead up to 10 million annual deaths worldwide, exceeding the incidence of cancer deaths. Although the design of new antibiotics is still one way to tackle the problem, pharmaceutical companies investigate far less into new drugs than 30 years ago. Incorporation of antibiotics into nanoparticle drug carriers (nanoantibiotics) is currently investigated as a promising strategy to make existing antibiotics regain antimicrobial strength and overcome certain types of microbial drug resistance. Many of these synthetic systems enhance the antimicrobial effect of drugs by protecting antibiotics from degradation and reducing their side effects. Nevertheless, they often cannot selectively target pathogenic bacteria and - due to their synthetic origin - may induce side-effects themselves. In this work, we present the characterisation of naturally derived outer membrane vesicles (OMVs) as biocompatible and inherently antibiotic drug carriers. We isolated OMVs from two representative strains of myxobacteria, Cystobacter velatus Cbv34 and Sorangiineae species strain SBSr073, a bacterial order with the ability of lysing other bacterial strains and currently investigated as sources of new secondary metabolites. We investigated the myxobacterias' inherent antibacterial properties after isolation by differential centrifugation and purification by size-exclusion chromatography. OMVs have an average size range of 145-194 nm. We characterised their morphology by electron cryomicroscopy and found that OMVs are biocompatible with epithelial cells and differentiated macrophages. They showed a low endotoxin activity comparable to those of control samples, indicating a low acute inflammatory potential. In addition, OMVs showed inherent stability under different storage conditions, including 4 °C, -20 °C, -80 °C and freeze-drying. OMV uptake in Gram-negative model bacterium Escherichia coli (E. coli) showed similar to better incorporation than liposome controls, indicating the OMVs may interact with model bacteria via membrane fusion. Bacterial uptake correlated with antimicrobial activity of OMVs as measured by growth inhibition of E. coli. OMVs from Cbv34 inhibited growth of E. coli to a comparable extent as the clinically established antibiotic gentamicin. Liquid-chromatography coupled mass spectrometry analyses revealed the presence of cystobactamids in OMVs, inhibitors of bacterial topoisomerase currently studied to treat different Gram-negative and Gram-positive pathogens. This work, may serve as an important basis for further evaluation of OMVs derived from myxobacteria as novel therapeutic delivery systems against bacterial infections." @default.
• W2894907175 created "2018-10-12" @default.
• W2894907175 creator A5012588438 @default.
• W2894907175 creator A5024696105 @default.
• W2894907175 creator A5025552969 @default.
• W2894907175 creator A5036587884 @default.
• W2894907175 creator A5066313683 @default.
• W2894907175 creator A5069222541 @default.
• W2894907175 creator A5077818118 @default.
• W2894907175 creator A5084255852 @default.
• W2894907175 date "2018-11-01" @default.
• W2894907175 modified "2023-09-27" @default.
• W2894907175 title "Biocompatible bacteria-derived vesicles show inherent antimicrobial activity" @default.
• W2894907175 cites W1270356811 @default.
• W2894907175 cites W1487118642 @default.
• W2894907175 cites W1747012886 @default.
• W2894907175 cites W1858567345 @default.
• W2894907175 cites W1970081203 @default.
• W2894907175 cites W1971853030 @default.
• W2894907175 cites W1975760212 @default.
• W2894907175 cites W1998624315 @default.
• W2894907175 cites W2000562577 @default.
• W2894907175 cites W2007499410 @default.
• W2894907175 cites W2010993726 @default.
• W2894907175 cites W2014368385 @default.
• W2894907175 cites W2020870088 @default.
• W2894907175 cites W2026571103 @default.
• W2894907175 cites W2035835006 @default.
• W2894907175 cites W2036978592 @default.
• W2894907175 cites W2036999399 @default.
• W2894907175 cites W2043364538 @default.
• W2894907175 cites W2049044362 @default.
• W2894907175 cites W2050139852 @default.
• W2894907175 cites W2057580939 @default.
• W2894907175 cites W2062214113 @default.
• W2894907175 cites W2063790803 @default.
• W2894907175 cites W2065114039 @default.
• W2894907175 cites W2071624135 @default.
• W2894907175 cites W2075551106 @default.
• W2894907175 cites W2081183202 @default.
• W2894907175 cites W2103928969 @default.
• W2894907175 cites W2104837454 @default.
• W2894907175 cites W2106046373 @default.
• W2894907175 cites W2111951615 @default.
• W2894907175 cites W2119129125 @default.
• W2894907175 cites W2144814819 @default.
• W2894907175 cites W2155444445 @default.
• W2894907175 cites W2156636796 @default.
• W2894907175 cites W2163123016 @default.
• W2894907175 cites W2223591983 @default.
• W2894907175 cites W2227867144 @default.
• W2894907175 cites W2331510077 @default.
• W2894907175 cites W2511419813 @default.
• W2894907175 cites W2536356236 @default.
• W2894907175 cites W2569453488 @default.
• W2894907175 cites W2604883943 @default.
• W2894907175 cites W262134620 @default.
• W2894907175 cites W2625053775 @default.
• W2894907175 cites W2736233594 @default.
• W2894907175 cites W2738548558 @default.
• W2894907175 cites W2753045771 @default.
• W2894907175 cites W2760243500 @default.
• W2894907175 cites W2772306649 @default.
• W2894907175 cites W2777733751 @default.
• W2894907175 cites W2789257567 @default.
• W2894907175 cites W2790701366 @default.
• W2894907175 cites W2790861736 @default.
• W2894907175 cites W2791722908 @default.
• W2894907175 cites W2792969792 @default.
• W2894907175 cites W2886368464 @default.
• W2894907175 cites W299579122 @default.
• W2894907175 doi "https://doi.org/10.1016/j.jconrel.2018.09.030" @default.
• W2894907175 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30292423" @default.
• W2894907175 hasPublicationYear "2018" @default.
• W2894907175 type Work @default.
• W2894907175 sameAs 2894907175 @default.
• W2894907175 citedByCount "77" @default.
• W2894907175 countsByYear W28949071752018 @default.
• W2894907175 countsByYear W28949071752019 @default.
• W2894907175 countsByYear W28949071752020 @default.
• W2894907175 countsByYear W28949071752021 @default.
• W2894907175 countsByYear W28949071752022 @default.
• W2894907175 countsByYear W28949071752023 @default.
• W2894907175 crossrefType "journal-article" @default.
• W2894907175 hasAuthorship W2894907175A5012588438 @default.
• W2894907175 hasAuthorship W2894907175A5024696105 @default.
• W2894907175 hasAuthorship W2894907175A5025552969 @default.
• W2894907175 hasAuthorship W2894907175A5036587884 @default.
• W2894907175 hasAuthorship W2894907175A5066313683 @default.
• W2894907175 hasAuthorship W2894907175A5069222541 @default.
• W2894907175 hasAuthorship W2894907175A5077818118 @default.
• W2894907175 hasAuthorship W2894907175A5084255852 @default.
• W2894907175 hasBestOaLocation W28949071752 @default.
• W2894907175 hasConcept C114851261 @default.
• W2894907175 hasConcept C1318750 @default.
• W2894907175 hasConcept C136229726 @default.
• W2894907175 hasConcept C185592680 @default.
• W2894907175 hasConcept C4937899 @default.

• next